Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Infect Control Hosp Epidemiol ; 45(3): 343-350, 2024 Mar.
Article in English | MEDLINE | ID: mdl-37887261

ABSTRACT

OBJECTIVE: To estimate cost savings after implementation of customized electronic duplicate order alerts. DESIGN: Alerts were implemented for microbiology tests at the largest public hospital in Victoria, Australia. These alerts were designed to pop up at the point of test ordering to inform the clinician that the test had previously been ordered and to suggest appropriate reordering time frames and indications. RESULTS: In a 6-month audit of urine culture (our most commonly ordered test) after alert implementation, 2,904 duplicate requesters proceeded with the request and 2,549 tests were cancelled, for a 47% reduction in test ordering. For fecal polymerase chain reaction (PCR), our second most common test, there was a 54% reduction in test ordering. For our most commonly ordered expensive test, hepatitis C PCR, there was a 42% reduction in test ordering: 25 tests were cancelled.Cancelled tests resulted in estimated savings of AU$52,382 (US$33,960) for urine culture, AU$34,914 (US$22,442) for fecal PCR, AU$4,506 (US$2,896) for hepatitis C PCR. For cancelled hepatitis B PCR and Epstein-Barr virus (EBV) and cytomegalovirus (CMV) serology, the cost savings was AU$8,472 (US$5445). The estimated financial cost saving in direct hospital costs for these 6 assays was AU$100,274 (US$67,925) over the 6-month period. Environmental waste cost saving by weight was estimated to be 280 kg. Greenhouse gas footprint, measured in carbon dioxide equivalent emissions for cancelled EBV and CMV serology tests, resulted in a saving of at least 17,711 g, equivalent to driving 115 km in a standard car. CONCLUSION: Customized alerts issued at the time of test ordering can have enormous impacts on reducing cost, waste, and unnecessary testing.


Subject(s)
Cytomegalovirus Infections , Epstein-Barr Virus Infections , Hepatitis C , Humans , Cost Savings , Herpesvirus 4, Human , Hospitals, Public
2.
J Correct Health Care ; 29(4): 293-298, 2023 08.
Article in English | MEDLINE | ID: mdl-37220011

ABSTRACT

The goal of the intensive outpatient program was to provide services to individuals who presented with co-occurring mental health and substance abuse disorders. These services were provided to incarcerated individuals during their involvement with a large Midwestern jail facility in efforts to reduce recidivism. Behavior change is a difficult process for any population, but for those with co-occurring mental health and substance abuse disorders, it is particularly challenging. With psychotherapeutic interventions, there may be therapeutic benefits that are occurring through outcomes such as increased insight into one's problems, attitudinal shifts, or improved coping that cannot be captured by tracking recidivism.


Subject(s)
Mental Disorders , Prisoners , Substance-Related Disorders , Humans , Prisoners/psychology , Jails , Outpatients , Substance-Related Disorders/epidemiology , Substance-Related Disorders/therapy , Mental Health , Mental Disorders/epidemiology , Mental Disorders/therapy
3.
Sex Health ; 19(5): 484-485, 2022 10.
Article in English | MEDLINE | ID: mdl-35786429

ABSTRACT

In response to the report by Abraham et al ., we present our observations of Trichomonas vaginalis (TV) detection in men tested at a public hospital laboratory in Melbourne, Australia, using a multiplex PCR. These studies provide valuable information about TV prevalence in urban communities.


Subject(s)
Sexual Health , Trichomonas Infections , Trichomonas Vaginitis , Trichomonas vaginalis , Ambulatory Care Facilities , Female , Humans , Male , Prevalence , Trichomonas Infections/diagnosis , Trichomonas Infections/epidemiology , Trichomonas Vaginitis/diagnosis , Trichomonas Vaginitis/epidemiology
4.
Pathology ; 53(2): 257-263, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33036769

ABSTRACT

Trichomonas vaginalis (TV) infection is the leading cause of non-viral sexually transmitted infection (STI) globally and is endemic in rural and remote Australia. However, current accurate prevalence data for TV in urban Australia are scarce as TV is not a notifiable infection outside of the Northern Territory (NT). This study evaluated Australian guidelines for TV testing and determined TV prevalence among patients at a large urban public hospital in Melbourne, Australia. A retrospective analysis of genitourinary samples screened for STIs by multiplex polymerase chain reaction (MPCR) between May 2017 and April 2019 was performed. A total of 7155 results (5064 females) were included in the analysis. A prevalence for TV of 1.7% (n=123) was found, which was higher than Neisseria gonorrhoeae (1.4%, n=103) but less than Chlamydia trachomatis (5%, n=358). The highest rate of TV (3%) was found in females aged 30-44 years (n = 48). Routine MPCR improved TV detection almost six-fold compared with clinician request based testing. Current targeted testing guidelines for TV were inadequate for case finding in an urban setting, and clinical request among symptomatic patients was rare. MPCR testing provides a comprehensive testing strategy for curable STI, and removes the need for clinical suspicion of TV. Implementation of MPCR for STI screening can improve TV detection in populations not normally suspected to be at risk and therefore potentially reduce disease transmission or complications associated with undiagnosed infection.


Subject(s)
Trichomonas Infections , Trichomonas vaginalis/isolation & purification , Adolescent , Adult , Aged , Australia/epidemiology , Child , Child, Preschool , Diagnostic Tests, Routine , Female , Genes, Protozoan , Humans , Infant , Male , Middle Aged , Multiplex Polymerase Chain Reaction , Northern Territory/epidemiology , Prevalence , Retrospective Studies , Rural Population , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/epidemiology , Trichomonas Infections/diagnosis , Trichomonas Infections/epidemiology , Trichomonas Infections/transmission , Trichomonas vaginalis/genetics
6.
Int J STD AIDS ; 26(13): 974-81, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25577597

ABSTRACT

We report a case of disseminated Mycobacterium haemophilum osteomyelitis in a patient with advanced HIV infection, who later developed recurrent immune reconstitution inflammatory syndrome after commencement of antiretroviral therapy. We review previous reports of M. haemophilum bone and joint infection associated with HIV infection and describe the management of M. haemophilum-associated immune reconstitution inflammatory syndrome, including the role of surgery as an adjunctive treatment modality and the potential drug interactions between antiretroviral and antimycobacterial agents.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , HIV Infections/complications , Immune Reconstitution Inflammatory Syndrome/complications , Mycobacterium Infections/diagnosis , Mycobacterium haemophilum/isolation & purification , Osteomyelitis/microbiology , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/microbiology , Adult , Ankle Joint , Anti-Bacterial Agents/therapeutic use , Anti-HIV Agents/therapeutic use , Debridement , HIV Infections/drug therapy , Humans , Immune Reconstitution Inflammatory Syndrome/microbiology , Magnetic Resonance Imaging , Male , Middle Aged , Mycobacterium Infections/drug therapy , Mycobacterium Infections/microbiology , Mycobacterium haemophilum/genetics , Osteomyelitis/diagnosis , Osteomyelitis/therapy , Polymerase Chain Reaction , Tenosynovitis/microbiology , Tenosynovitis/surgery
7.
Med J Aust ; 195(9): 530-3, 2011 Nov 07.
Article in English | MEDLINE | ID: mdl-22060088

ABSTRACT

OBJECTIVE: To assess the frequency of, and risk factors for, colonisation with vancomycin-resistant enterococci (VRE), Clostridium difficile and extended-spectrum ß-lactamase (ESBL)-producing organisms in residential aged care facilities (RACFs). DESIGN, SETTING AND PARTICIPANTS: We conducted a point prevalence survey in October-November 2010 in three RACFs associated with our health service. A single faecal sample was collected from each participating resident and screened for the presence of VRE, C. difficile and ESBL-producing organisms. Presence of risk factors for antibiotic-resistant organisms was identified using a questionnaire. MAIN OUTCOME MEASURES: Prevalence of colonisation with VRE, C. difficile and ESBL-producing organisms; molecular typing of ESBL-producing organisms; prevalence of risk factors including presence of a urinary catheter, recent inpatient stay in an acute care setting and recent antibiotic consumption. RESULTS: Of 164 residents in the three facilities, 119 (73%) were screened. Mean age of screened residents was 79.2 years, and 61% were women; 74% had resided in the RACF for > 12 months, 21% had been given antibiotics within the past month and 12% had been in an acute care centre within the past 3 months. Overall rates of VRE (2%) and C. difficile (1%) colonisation were low, but ESBL-producing Escherichia coli was detected in 14 residents (12%) overall, with half of these residing in one wing of an RACF (27% of wing residents tested). Ten of the 14 ESBL-producing isolates had identical molecular typing patterns and belonged to genotye CTX-M-9. Eight of 13 residents had persistent colonisation on repeat testing 3 months later. CONCLUSION: We found a high prevalence of multiresistant ESBL-producing E. coli in RACF residents. A clonal relatedness of isolates suggests possible transmission within the facility. RACFs should have programs emphasising processes that will limit spread of these organisms, namely good hand hygiene compliance, enhanced environmental cleaning and dedicated antimicrobial stewardship programs.


Subject(s)
Carrier State/epidemiology , Clostridioides difficile , Clostridium Infections/epidemiology , Drug Resistance, Bacterial , Enterococcus , Escherichia coli Infections/epidemiology , Gram-Positive Bacterial Infections/epidemiology , Homes for the Aged , Nursing Homes , Adult , Aged , Aged, 80 and over , Clostridioides difficile/drug effects , Clostridium Infections/drug therapy , Drug Resistance, Multiple, Bacterial , Enterococcus/drug effects , Escherichia coli Infections/drug therapy , Female , Gram-Positive Bacterial Infections/drug therapy , Humans , Male , Middle Aged , Prevalence , Risk Factors , Vancomycin Resistance , Victoria/epidemiology , beta-Lactam Resistance
SELECTION OF CITATIONS
SEARCH DETAIL
...